Stoke Therapeutics, Inc. - STOK
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors LP | 5.8% | 3,336,697 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Baker Bros. Advisors (GP) LLC | 5.8% | 3,336,697 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Julian C. Baker | 5.8% | 3,336,697 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Felix J. Baker | 5.8% | 3,336,697 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 9.8% | 5,600,920 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 9.8% | 5,600,920 | View |
| Nov 14, 2025 | SCHEDULE 13G | The Toronto-Dominion Bank | 5.8% | 3,173,258 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Cowen Financial Products LLC | 0.0% | 0 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | FMR LLC | 12.5% | 6,865,057 | View |
| Nov 05, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 12.5% | 6,865,057 | View |
| Oct 17, 2025 | SCHEDULE 13G/A | BlackRock, Inc. | 6.8% | 3,732,540 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.